Stocks Hitting 52-Week Lows

Hatteras Financial

shares reached a new 52-week low of $16.173. Hatteras Financial's trailing-twelve-month profit margin is -6.57%. Myriad Genetics

shares touched a new 52-week low of $20.14. Myriad Genetics expressed concerns over CMS not valuing BRCA 2 gene in 81211 code, CMS 81211 payment rate. Mizuho Securities downgraded the stock from Buy to Neutral. Gyrodyne Co. of America

shares touched a new 52-week low of $67.52. Gyrodyne Co. of America shares have dropped 4.52% over the past 52 weeks, while the S&P 500 index has gained 29.11% in the same period. Can-Fite BioPharma

shares reached a new 52-week low of $5.551 after the company's subsidiary OphthaliX

reported that its phase III study with its licensed drug CF101 for moderate-to-severe dry eye syndrome did not meet primary efficacy endpoint.